The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Open accessAbstract
We identified a family of proteins termed ASPP. ASPP1 is a protein homologous to 53BP2, the C-terminal half of ASPP2. ASPP proteins interact with p53 and specifically enhance p53-induced apoptosis but not cell cycle arrest. Inhibition of endogenous ASPP function suppresses the apoptotic function of endogenous p53 in response to apoptotic stimuli. ASPP enhance the DNA binding and transactivation function of p53 on the promoters of proapoptotic genes in vivo. Two tumor-derived p53 mutants with reduced apoptotic function were defective in cooperating with ASPP in apoptosis induction. The expression of ASPP is frequently downregulated in human breast carcinomas expressing wild-type p53 but not mutant p53. Therefore, ASPP regulate the tumor suppression function of p53 in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The miR-21 targets we identified included p53 homologue, p63, p53 activators JMY, TOPORS, TP53BP2, DAXX, and HNRPK, which can stabilize p53 protein levels by interfering with MDM2 and/or act as p53 transcriptional cofactors, assisting p53 in transactivating genes that can induce apoptosis and growth arrest (21)(22)(23)(24)(25)(26).”
From MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells (2008) · cites this paper as [23]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2
Gorina, S. S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 575
Two cellular proteins that bind to wild-type but not mutant p53.
Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. L., & Fields, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6098 · Cited by 432
In vivo gene expression profile analysis of human breast cancer progression.
Sgroi, D. C., Teng, S., ROBINSON, G. C., LeVangie, R., Hudson, J. R., & Elkahloun, A. G. (1999) · PubMed · Cited by 390
Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function
Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 278
Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278
Self-citationA Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P. A., Haupt, Y., Prives, C. L., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 277
Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2
Iwabuchi, K., Li, B., Massa, H. F., Trask, B. J., Date, T., & Fields, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26061 · Cited by 206
Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179
Self-citation
Cited by
Sorted by citations
Items 501–600 of 663
Joerger, A. C., Friedler, A., & Fersht, A. R. (2007) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_17 · Cited by 6
The multifunctional proline-rich domain of p53 tumor suppressor
Zhang, Y., & Dutta, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189326 · Cited by 6
Fu, X., Zhang, W., Li, S., Ling, N., Yang, Y., & Zhang, D. (2022) · Aging · doi:10.18632/aging.204286 · Cited by 5
Tomoda, K., Takahashi, N., Hibi, Y., Asamitsu, K., Ishida, H., Kondo, T., Fujii, Y., & Okamoto, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00723.x · Cited by 5
In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.
Chen, Y., Yan, W., He, S., Chen, J., Chen, D., Zhang, Z., Liu, Z., Ding, X., & Wang, A. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2014.07.05 · Cited by 5
The Three-Dimensional Structure of p53
Stavridi, E. S., Huyen, Y., Sheston, E. A., & Halazonetis, T. D. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_2 · Cited by 5
Freewoman, J. M., Snape, R., & Cui, F. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1904554 · Cited by 5
Rieger, I., Tsintari, V., Overkamp, M., Fend, F., Lopez, C. D., Schittenhelm, M. M., & Kampa-Schittenhelm, K. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.727203 · Cited by 5
Construction of a full-length iASPP expression plasmid pcDNA3.1(+)/iASPP and its biological activity
Liu, Z., Gao, X., Cai, Y., Yang, X. X., Fu, X., Chen, J., Zhang, X., & Xin, H. (2009) · Plasmid · doi:10.1016/j.plasmid.2009.01.004 · Cited by 5
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
Che‐ating death: CHE1/AATF protects from p53‐mediated apoptosis
Jackson, J. G., & Lozano, G. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.258 · Cited by 4
Okoshi, R., Kubo, N., Nakashima, K., Shimozato, O., Nakagawara, A., & Ozaki, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.114 · Cited by 4
Lü, X. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397833-2.00009-1 · Cited by 4
Cell Polarity: A Key Defence Mechanism Against Infection and Cancer Cell Invasion?
Wang, Y., & Lü, X. (2015) · Springer eBooks · doi:10.1007/978-3-319-14466-5_7 · Cited by 4
YAP and p73: A Matter of Mutual Specificity in Tumor Suppression
Donzelli, S., Strano, S., & Blandino, G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6220-0_8 · Cited by 4
Hydrophobic Scale: a Second Parameter to Elucidating Various Specific Ligand-Protein Interactions
Numao, N., Fujii, H., Fukazawa, Y., Hanagata, N., & Tanaka, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.377 · Cited by 4
Yu, J., Li, L., & Huang, C. (2017) · Medical Science Monitor · doi:10.12659/msm.905403 · Cited by 3
Guven‐Maiorov, E., Sakakibara, N., Ponnamperuma, R. M., Dong, K., Matar, H., King, K. E., & Weinberg, W. C. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23405 · Cited by 3
Song, X., Du, J., Zhu, W., Jin, P., & Ma, F. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.12.040 · Cited by 3
Zhang, N., Han, G., Li, C., Huang, L., Liu, Q., Lin, M., Xu, B., & Xu, J. (2024) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2024.106196 · Cited by 3
Active Learning for the Prediction of Asparagine/Aspartate Hydroxylation Sites on Proteins
Iyuke, F. O., Green, J. R., & Willmore, W. G. (2011) · Computational Intelligence and Bioinformatics / 755: Modelling, Identification, and Simulation · doi:10.2316/p.2011.753-034 · Cited by 3
Mechanisms of apoptosis in ovarian cancer: The small molecule targeting
Philemon, N. U., Choene, M. S., & Motadi, L. R. (2015) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms2014.1081 · Cited by 3
Brooksbank, C. (2001) · Nature reviews. Cancer · doi:10.1038/35101044 · Cited by 3
Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer
Patel, K. D., Barasiya, Y. V., Patel, J. B., & Patel, P. S. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104920 · Cited by 3
Ma, A., & Dai, X. (2019) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-019-00332-z · Cited by 3
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3
Acosta‐Iborra, B., Puente-Santamaría, L., Berrouayel, Y., del Peso, L., & Jiménez, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3954034/v1 · Cited by 2
Tsintari, V., Walter, B., Fend, F., Overkamp, M., Rothermundt, C. A., Lopez, C. D., Schittenhelm, M. M., & Kampa-Schittenhelm, K. M. (2022) · BMC Cancer · doi:10.1186/s12885-022-09726-7 · Cited by 2
Li, S., Li, X., Li, Z., Li, B., Zhou, C., Chen, F., Qiu, T., & Li, Z. (2023) · Lecture notes in computer science · doi:10.1007/978-981-99-8555-5_40 · Cited by 2
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells
Rich, J., Bennaroch, M., Notel, L., Patalakh, P., Alberola, J., Issa, F., Opolon, P., Bawa, O., Rondof, W., Marchais, A., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00097-z · Cited by 2
Liu, H., Ma, L., Wang, H., Huang, X., Peng, Y., Yang, Z., Xiao, J., Huang, H., Yang, Q., Sun, J., et al. (2025) · Inflammation · doi:10.1007/s10753-024-02235-8 · Cited by 2
Jia, F., Jiang, W., Zhang, Y., Zhang, L., Han, T., Liu, D., Xue, J., & Deng, F. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-09999-x · Cited by 2
Mutant p53 Reactivation as a Novel Strategy for Cancer Therapy
Selivanova, G., Bykov, V. J. N., & Wiman, K. G. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_18 · Cited by 2
An Identity Crisis for a Cancer Gene: Subcellular Location Determines ASPP1 Function
Manfredi, J. J. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.003 · Cited by 2
Cluster Analysis of p53 Binding Site Sequences Reveals Subsets with Different Functions
Lim, J., Latysheva, N. S., Iggo, R. D., & Barker, D. (2016) · Cancer Informatics · doi:10.4137/cin.s39968 · Cited by 2
Kotula‐Balak, M., Duliban, M., Gurgul, A., Krakowska, I., Grzmil, P., Bilińska, B., & Wolski, J. K. (2021) · Andrologia · doi:10.1111/and.14222 · Cited by 2
Aoyama, B. B., Zanetti, G. G., Dias, E. V., Athié, M. C. P., Lopes‐Cendes, Í., & Vieira, A. S. (2022) · Hippocampus · doi:10.1002/hipo.23417 · Cited by 2
iASPP regulates neurite development by interacting with Spectrin proteins
Wang, J., Jia, C., Gao, Q., Zhang, J., & Gu, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1154770 · Cited by 2
Functional Analysis and Characterization of Epstein Barr Virus Latent Membrane Protein 2b
Tomaszewski-Flick, M. J. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Renault, A. D., & Axton, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00444-x · Cited by 2
Stochastic transcription in the p53-mediated response to DNA damage is modulated by burst frequencyPreprint
Friedrich, D., Friedel, L., Herrmann, A., Preibisch, S., & Loewer, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/679449 · Cited by 2
Functional Analysis of the Human p53 Tumor Suppressor and its Mutants Using Yeast
Inga, A., Storici, F., & Resnick, M. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5963-6_10 · Cited by 2
Babaei, F., Abdzadeh, S., Bakhshandeh, N., Derakhshandeh, Z., Dehghan-Nayeri, M. J., Ardakani, M. R. S., Babaei, E., & Mahdavi, M. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00804-8 · Cited by 1
Apoptosis: Natural Product-Derived Small Molecules as Therapeutics
Gayen, S., Ghosh, S., Gupta, B. D., & Haldar, P. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_18 · Cited by 1
Nonlinear dynamics in the p53 signaling network
Feng, L., ZHANG, X., & Wang, W. (2014) · Zhongguo kexue. Wulixue Lixue Tianwenxue · doi:10.1360/sspma2014-00121 · Cited by 1
Zhang, J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382816.005 · Cited by 1
A Texture Enhanced Feature Fusion Method for Small Object Detection
Zhou, X., & Li, S. (2021) · International Conference on Information Technology in Medicine and Education · doi:10.1109/itme53901.2021.00033 · Cited by 1
ASPP1/2 positive patients with invasive breast cancers have good prognosis
Wang, C., Li, K., An, J., Lv, X., Ma, W., Wang, Y., Meng, N.-L., Tian, Y., & Zhao, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20613 · Cited by 1
Elwakkad, A., el Din, A. A. G., Hebishy, M. A., & Abou-Seif, H. S. (2024) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_362_23 · Cited by 1
Saipi, M. B., Ruiba, A., Schittenhelm, M. M., Blumenstock, G., Győrffy, B., Fazio, S., Hafner, M., Ahrens, A.-L., Aldinger, L., Aellig, V., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07190-8 · Cited by 1
Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitro
Lotz, R., Osterburg, C., Chaikuad, A., Weber, S., Akutsu, M., Machel, A. C., Beyer, U., Gebel, J., Löhr, F., Knapp, S., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-024-07320-2 · Cited by 1
Transcriptional Activation by p53: Mechanisms and Targeted Genes
MacLachlan, T. K., & El‐Deiry, W. S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_3 · Cited by 1
p53, p63 and p73 Network in Breast Cancers
Leong, C. (2011) · InTech eBooks · doi:10.5772/20337 · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 2
Use of minimally invasive methods of treatment of neoplasms of the thyroid gland
Mazur, O. V., & Олександрович, П. В. (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-2-70 · Cited by 1
Daba, T. M., Huang, X., Yagudin, T., Yang, Y., Wang, J., Fu, X., Zhao, Y., Gao, H., Zhou, Y., Pan, Z., et al. (2021) · Frigid Zone Medicine · doi:10.2478/fzm-2021-0007 · Cited by 1
Clavería-Cabello, A., Arechederra, M., Berasain, C., Fernández‐Barrena, M. G., & Avila, M. A. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.77 · Cited by 1
p53 Inhibitors as Cancer Sensitizing Agents
Maina, F., & Dono, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-474-2_12 · Cited by 1
Bourdon, J., & Lane, D. P. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap223 · Cited by 1
Update on The Big C: complexity and cross-talk between pathways
Downward, J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00257-x · Cited by 1
The p53 Pathway, Cancer and Aging
Braithwaite, A. W., & Edwards, S. J. (2003) · Springer eBooks · doi:10.1007/978-94-017-0669-8_8 · Cited by 1
20 Years of DNA Damage Signaling to p53
McLure, K. G., & Kastan, M. B. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_3 · Cited by 1
Manfredi, J. J. (2009) · Genes & Development · doi:10.1101/gad.1778309 · Cited by 1
The p53 Transcription Factor as Therapeutic Target in Cancer
Asker, C., Bykov, V. J. N., Méndez‐Vidal, C., Selivanova, G., Wilhelm, M., & Wiman, K. G. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_7 · Cited by 1
Cancer Therapy by Reactivation of the p53 Apoptosis Pathway
Stridh, H., Bykov, V. J. N., Selivanova, G., & Wiman, K. G. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch35 · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_4 · Cited by 1
Characterization and Preclinical Treatment of Rotational Force-Induced Brain InjuryPreprint
Umfress, A., Chakraborti, A., Devi, S. P. S., Adams, R., Epstein, D., Massicano, A. V. F., Sorace, A. G., Singh, S., Hossian, M. I., Andrabi, S. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.20.500670 · Cited by 1
Mutant IDH uncouples p53 from target gene regulation to disable tumor suppressionPreprint
Martin, C. P., Sullivan, W. B., Brinkman, J. A., Scoville, D. M., Yashinskie, J. J., Tian, S., Mezzadra, R., Ho, Y.-J., Koche, R. P., Baslan, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615916 · Cited by 1
Joerger, A. C., Friedler, A., & Fersht, A. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_17 · Cited by 1
Roh, J.-L., & Koch, W. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8815-6_12
Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation
Latonen, L. (2003) · Työväentutkimus Vuosikirja
Janke, K. (2013) · DuEPublico (University of Duisburg-Essen)
On the structure-function relationship of p73
Nyman, U. (2009) · Figshare
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
A computational approach to discovering p53 binding sites in the human genome
Lim, J. (2013) · St Andrews Research Repository (St Andrews Research Repository)
Molecular mechanisms of growth suppression by pharmacologically activated p53
Hedström, E. (2009) · Figshare
p73 Affects Cell Fate and Tumorigenesis
Ramadan, S. M., Sayan, E., Oberst, A., Chikh, A., Pietroni, V., Rufini, A., Melino, G., & Bernassola, F. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch20
Involvement of p53 in the S-phase Checkpoint during Nucleotide Deficiencies
Heyer, C. L. (2011) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/4zf5-2439
Expressão diferencial de mRNA em células de cultivo infectadas ple herpesvírus bovino 5
Cagnini, D. Q. (2014) · Americanae (AECID Library)
Post-translational Modifications of the p53 Transcription Factor
Brooks, C. L., & Gu, W. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_15
Molecular mechanisms involved in the induction of pluripotency
Acero, G. R. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4322
Achievements, Questions Arising and Future Outlook on the Path to Discover New Medicinal Compounds
Fang, E. F., & Ng, T. B. (2013) · Springer eBooks · doi:10.1007/978-94-007-6214-5_27
Epigenetics in Pediatric Cancers
Ciarapica, R., Raimondi, L., Verginelli, F., & Rota, R. (2011) · Wiley eBooks · doi:10.1002/9781118005743.ch9
Studies of mutant p53-targeting small molecules
Zache, N. (2007) · Figshare
TP53BP2 (tumor protein p53 binding protein, 2)
Van, H. K., Wang, Z., & Lopez, C. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/46004
The role of microRNAs in the p53 tumor suppressor pathway
Zhang, X. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3171
Enge, M. (2009) · Figshare
Skorta, I. (2009) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1857
Pharmacological targeting of mutant p53 family members
Rökaeus, N. (2011) · Figshare
From peptides to proteins: lessons from my years at the Centre for Protein Engineering
Friedler, A. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq080
The leukemogenic role of (iASPP) in acute leukemia
Almawgood, S. A., Hasan, N. S., & Yousef, M. (2007)
The Structure and Interactions of the Proline-rich Domain
Rotem, S., Katz, C., Benyamini, H., Lebendiker, M., Veprintsev, D. B., Danieli, T., Friedler, A., & InstituteofChemistry, F. ‡. (2008)
Lora, V. (2010) · Americanae (AECID Library)
Regulation of apoptosis by mar binding protein smar1
Sinha, S. (2009) · INFLIBNET
An investigation of p53’s differential activation of cell cycle arrest and apoptosis
Zhang, Y. (2008) · eSpace (Curtin University)
Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)
Calabria: sun, sand, and cell death
Bagetta, G., Corasaniti, M. T., Oberst, A., & Brüne, B. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401100
Metadata
- Authors
- Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X.
- Affiliations
- Ludwig Cancer Research (GB)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 8
- Issue
- 4
- Pages
- 781-794
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2087732778
- Cited by
- 664
- References
- 22
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 20 · 2022: 16 · 2021: 26 · 2020: 13 · 2019: 20 · 2018: 8 · 2017: 27 · 2016: 18 · 2015: 23 · 2014: 37 · 2013: 35 · 2012: 31
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ASPP1, ASPP2, p53, apoptosis, p53 DNA binding, p53 transactivation, tumor suppression, breast cancer, mutant p53, cell cycle arrest
- MeSH terms
- Breast Neoplasms, Carcinoma, Carrier Proteins, Cell Separation, Female, Flow Cytometry, Humans, Microscopy, Fluorescence, Molecular Sequence Data, Peptide Fragments, Promoter Regions, Genetic, Proto-Oncogene Proteins, Tumor Cells, Cultured, Transcriptional Activation, Tumor Suppressor Protein p53, Cyclins, Apoptosis, Protein Structure, Tertiary, Proto-Oncogene Proteins c-bcl-2, Cyclin-Dependent Kinase Inhibitor p21, Apoptosis Regulatory Proteins, bcl-2-Associated X Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review